Abeona Therapeutics (ABEO) Interest Coverage Ratio Growth (3y) (2014 - 2026)
Abeona Therapeutics (ABEO) Interest Coverage Ratio Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
29.25% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
-16.86% |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Abeona Therapeutics |
309.15 Mn |
140.88 Mn |
6.02 Mn |
38.48% |
| Date | Value |
|---|
| Mar 31, 2026 |
38.48% |
| Dec 31, 2025 |
48.41% |
| Sep 30, 2025 |
23.59% |
| Jun 30, 2025 |
15.90% |
| Mar 31, 2025 |
42.21% |
| Dec 31, 2024 |
74.03% |
| Sep 30, 2024 |
13.85% |
| Jun 30, 2024 |
-22.15% |
| Mar 31, 2024 |
-13.56% |
| Dec 31, 2023 |
-126.48% |
| Sep 30, 2023 |
-184.08% |
| Jun 30, 2023 |
-87.27% |
| Mar 31, 2023 |
-14.05% |
| Dec 31, 2021 |
53.94% |
| Sep 30, 2021 |
84.31% |
| Jun 30, 2021 |
87.02% |
| Mar 31, 2021 |
85.76% |
| Dec 31, 2020 |
89.40% |
| Sep 30, 2020 |
87.94% |
| Jun 30, 2020 |
82.30% |
